Imagine that, entities forecasting revenue before the pricing was even announced.
This is the utter rubbish that investors are presented with and have to endure when market makers engage in deceptive manipulation.
The savvy investor always sees through the garbage but unfortunately there are many that are just so easily influenced.
The reality is that it is now very difficult to negatively argue the potential of this stock and at the same time expect to retain any credulity whatsoever.
Ryoncil (US $1500000 /treatment)
FDA Approved
Fully funded
Molly
(20min delay)